Understanding a Rebalancing Therapy Option for Hemophilia
Join us for an educational session exploring a rebalancing treatment option for hemophilia.
You’ll hear:
- The science behind rebalancing therapy
- Clinical trial data
- Safety information
- Information on administration
- Shared decision-making tips for patients and caregivers
Speaker
-
Bradley SchoenfeldAdvocacy and Community Engagement Team LeadBradley Schoenfeld, Advocacy and Community Engagement Team Lead, Pfizer
Brad serves as Pfizer’s advocacy and community engagement team lead within its Rare Disease Patient Solutions organization. He brings over 15 years of experience supporting the hemophilia community, patient education and fostering connections in roles prior to joining Pfizer in 2020.
English 
Español de Puerto Rico